Igor Vujic

2.4k total citations
50 papers, 1.4k citations indexed

About

Igor Vujic is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Igor Vujic has authored 50 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 19 papers in Oncology and 18 papers in Immunology. Recurrent topics in Igor Vujic's work include Melanoma and MAPK Pathways (10 papers), Cutaneous Melanoma Detection and Management (9 papers) and Psoriasis: Treatment and Pathogenesis (7 papers). Igor Vujic is often cited by papers focused on Melanoma and MAPK Pathways (10 papers), Cutaneous Melanoma Detection and Management (9 papers) and Psoriasis: Treatment and Pathogenesis (7 papers). Igor Vujic collaborates with scholars based in Austria, United States and Italy. Igor Vujic's co-authors include Martina Sanlorenzo, Klemens Rappersberger, Susana Ortiz‐Urda, Christian Posch, Pietro Quaglino, Adil Daud, Alain P. Algazi, Babak Itzinger-Monshi, Kevin Lin and Matthew A. Gubens and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Igor Vujic

50 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Igor Vujic Austria 22 691 488 338 227 133 50 1.4k
Christian Posch Austria 23 575 0.8× 714 1.5× 286 0.8× 184 0.8× 104 0.8× 81 1.5k
Martina Sanlorenzo Italy 23 907 1.3× 583 1.2× 380 1.1× 269 1.2× 140 1.1× 53 1.6k
Luigia Stefania Stucci Italy 21 759 1.1× 642 1.3× 482 1.4× 112 0.5× 162 1.2× 46 1.5k
Benedetta Belloni Germany 18 585 0.8× 587 1.2× 380 1.1× 173 0.8× 64 0.5× 32 1.3k
Peter Kaskel Germany 18 458 0.7× 541 1.1× 205 0.6× 271 1.2× 127 1.0× 43 1.5k
Catalin Mihalcioiu Canada 14 422 0.6× 391 0.8× 155 0.5× 131 0.6× 156 1.2× 38 1000
Jerry Marsden United Kingdom 19 862 1.2× 403 0.8× 251 0.7× 524 2.3× 84 0.6× 32 1.6k
Mark Harries United Kingdom 25 1.1k 1.5× 579 1.2× 354 1.0× 59 0.3× 221 1.7× 62 1.9k
Simone M. Goldinger Switzerland 27 1.6k 2.3× 1.3k 2.8× 530 1.6× 193 0.9× 399 3.0× 82 2.6k
Zélia M. Corrêa United States 21 424 0.6× 430 0.9× 185 0.5× 60 0.3× 117 0.9× 127 1.4k

Countries citing papers authored by Igor Vujic

Since Specialization
Citations

This map shows the geographic impact of Igor Vujic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Vujic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Vujic more than expected).

Fields of papers citing papers by Igor Vujic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Igor Vujic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Vujic. The network helps show where Igor Vujic may publish in the future.

Co-authorship network of co-authors of Igor Vujic

This figure shows the co-authorship network connecting the top 25 collaborators of Igor Vujic. A scholar is included among the top collaborators of Igor Vujic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Igor Vujic. Igor Vujic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sanlorenzo, Martina, Igor Vujic, Martina Hammer, et al.. (2025). Systemic IFN-I combined with topical TLR7/8 agonists promotes distant tumor suppression by c-Jun-dependent IL-12 expression in dendritic cells. Nature Cancer. 6(1). 175–193. 6 indexed citations
2.
Itzinger-Monshi, Babak, et al.. (2021). Psoriasis ist mit Lingua plicata jedoch nicht mit Lingua geographica assoziiert: eine prospektive Fall‐Kontroll‐Studie. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 19(8). 1170–1177. 1 indexed citations
3.
Bauer, Thomas, Buck Hanson, Craig W. Herbold, et al.. (2019). Hair eruption initiates and commensal skin microbiota aggravate adverse events of anti-EGFR therapy. Science Translational Medicine. 11(522). 28 indexed citations
4.
Weihsengruber, Felix, et al.. (2019). Clinical melanoma characteristics and survival—a single-center retrospective study between 2000 and 2010. Wiener Medizinische Wochenschrift. 169(13-14). 323–330. 2 indexed citations
5.
Sanlorenzo, Martina, Igor Vujic, Mauro Novelli, et al.. (2018). BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti–PD-1 Antibody. Clinical Cancer Research. 24(14). 3377–3385. 30 indexed citations
6.
Vujic, Igor, Robert Herman, Martina Sanlorenzo, et al.. (2017). 014 Apremilast in psoriasis - a prospective real-world study. Journal of Investigative Dermatology. 137(10). S195–S195. 11 indexed citations
7.
Posch, Christian, et al.. (2017). The role of wide local excision for the treatment of severe hidradenitis suppurativa (Hurley grade III): Retrospective analysis of 74 patients. Journal of the American Academy of Dermatology. 77(1). 123–129.e5. 49 indexed citations
8.
Vujic, Igor, et al.. (2017). 051 Differences in the response of dermatologic symptoms and muscular strength after intravenous immunoglobulin therapy in dermatomyositis patients. Journal of Investigative Dermatology. 137(10). S201–S201. 1 indexed citations
9.
Sanlorenzo, Martina, Igor Vujic, Christian Posch, et al.. (2016). Oncogenic KIT mutations in different exons lead to specific changes in melanocyte phospho-proteome. Journal of Proteomics. 144. 140–147. 5 indexed citations
10.
Posch, Christian, Igor Vujic, Babak Itzinger-Monshi, et al.. (2016). Searching for the Chokehold of NRAS Mutant Melanoma. Journal of Investigative Dermatology. 136(7). 1330–1336. 12 indexed citations
11.
Itzinger-Monshi, Babak, Danijel Kivaranovic, Willi Oberaigner, et al.. (2016). The burden of malignant melanoma – Lessons to be learned from Austria. European Journal of Cancer. 56. 45–53. 31 indexed citations
12.
Dapavo, Paolo, Igor Vujic, Maria Teresa Fierro, Pietro Quaglino, & Martina Sanlorenzo. (2016). The infliximab biosimilar in the treatment of moderate to severe plaque psoriasis. Journal of the American Academy of Dermatology. 75(4). 736–739. 28 indexed citations
13.
Sanlorenzo, Martina, Igor Vujic, Pietro Quaglino, et al.. (2015). Synergy of molecular targeted approaches and immunotherapy in melanoma: preclinical basis and clinical perspectives. Expert Opinion on Biological Therapy. 15(10). 1491–1500. 6 indexed citations
14.
Posch, Christian, Igor Vujic, Martina Sanlorenzo, et al.. (2015). Combined Inhibition of MEK and Plk1 Has Synergistic Antitumor Activity in NRAS Mutant Melanoma. Journal of Investigative Dermatology. 135(10). 2475–2483. 54 indexed citations
15.
Goldenberg, Alina, Igor Vujic, Martina Sanlorenzo, & Susana Ortiz‐Urda. (2015). Melanoma risk perception and prevention behavior among African-Americans: the minority melanoma paradox. Clinical Cosmetic and Investigational Dermatology. 8. 423–423. 17 indexed citations
16.
Posch, Christian, Alfonso Latorre, Michelle B. Crosby, et al.. (2015). Detection of GNAQ mutations and reduction of cell viability in uveal melanoma cells with functionalized gold nanoparticles. Biomedical Microdevices. 17(1). 15–15. 23 indexed citations
17.
Vujic, Igor, et al.. (2014). Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma. PLoS ONE. 9(9). e107255–e107255. 33 indexed citations
18.
Itzinger-Monshi, Babak, et al.. (2014). Efficacy of intravenous immunoglobulins in livedoid vasculopathy: Long-term follow-up of 11 patients. Journal of the American Academy of Dermatology. 71(4). 738–744. 43 indexed citations
19.
Sanlorenzo, Martina, Igor Vujic, Christian Posch, et al.. (2014). Melanoma immunotherapy. Cancer Biology & Therapy. 15(6). 665–674. 67 indexed citations
20.
Vujic, Igor, Christian Posch, Martina Sanlorenzo, et al.. (2014). Mutant NRASQ61 shares signaling similarities across various cancer types - potential implications for future therapies. Oncotarget. 5(17). 7936–7944. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian Posch Breakdown of academic impact, for papers by Martina Sanlorenzo Breakdown of academic impact, for papers by Luigia Stefania Stucci Breakdown of academic impact, for papers by Benedetta Belloni Breakdown of academic impact, for papers by Peter Kaskel Breakdown of academic impact, for papers by Catalin Mihalcioiu Breakdown of academic impact, for papers by Jerry Marsden Breakdown of academic impact, for papers by Mark Harries Breakdown of academic impact, for papers by Simone M. Goldinger Breakdown of academic impact, for papers by Zélia M. Corrêa
Rankless by CCL
2026